Cipla Announces Settlement of REVLIMID® (lenalidomide) Capsules Patent Litigation
Go back to Cipla Announces Settlement of REVLIMID® (lenalidomide) Capsules Patent Litigation| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 61.50 +0.35 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.15 | 52 Week High | $77.12 | |||
| Open | $61.40 | 52 Week Low | $49.03 | |||
| Day High | $61.59 | P/E | 39.94 | |||
| Day Low | $60.60 | EPS | $1.54 | |||
| Volume | 14,902,587 | |||||
| Celgene Corp. (NASDAQ: CELG) | Delayed: 108.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $108.24 | 52 Week High | $127.00 | |||
| Open | $7.85 | 52 Week Low | $93.05 | |||
| Day High | $108.24 | P/E | 32.12 | |||
| Day Low | $108.24 | EPS | $3.37 | |||
| Volume | 0 | |||||
